Adjusted Net Income -- $12.6 million, or $0.31 per share, for the third quarter, with sequential earnings improvement ...

Press Release - With one in every 25 COP30 attendees a fossil fuel lobbyist, massive industry presence intensifies calls to protect climate negotiations from corporate capture ...

Evidence-based recommendations on lorlatinib (Lorviqua) for treating ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor in adults. Lorlatinib is also ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...

Wilson raised the full-year 2025 revenue guidance to $735 million to $740 million, representing 24% to 25% year-over-year growth. He stated, "This outlook contemplates continued strong volume growth ...

Earlier this week, BetMGM, a joint venture between MGM Resorts International and Entain, announced a strong third-quarter performance, with net revenue rising 23% year-over-year and full-year guidance ...

BERLIN -- Almost half of patients with advanced ALK-positive non-small cell lung cancer (NSCLC) have lived 7 years or longer following initial treatment with the ALK inhibitor alectinib (Alecensa), an ...

AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...

What will your day look like in terms of health, romance, finance and fortune? Read everything here. Scorpio Money Horoscope Today Financial results will improve, and your overall performance will be ...

Johnson shared that full-year 2025 adjusted EBITDA guidance has been tightened to $1.50 billion to $1.55 billion, factoring in the benefit from the legal settlement and operating results through the ...

Aroa records fourth consecutive quarter of positive net cash flow Highest quarter on record for high-margin Myriad products with NZ$10.2 million in sales FY26 guidance of NZ$92-100 million reaffirmed ...